ADREVIEW [123I] 74 MBq/mL, solution injectable
solution injectable
intraveineuse
Autorisation active
Procédure nationale
Commercialisée
2/22/2005
GE HEALTHCARE
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!